Soaring drug costs have led to a spike in US spending on cancer treatment , which has doubled since 2013 . Spending on cancer drugs has doubled over the past five years, and little wonder: Every new cancer drug brought to market last year cost $100,000 or more, according to a new report. Treatment with each of the new cancer drugs introduced in 2017 costs at least $ 500 , while the average price of a new drug brought to market was $ 150,000 , compared with $ 79,000 five years ago . By 2020 , US costs are forecast to double yet again , while the global market for cancer therapeutic medicines is expected to reach $ 200bn .
Soaring drug costs have led to a spike in US spending on cancer treatment , which has doubled since 2013 . Treatment with each of the new cancer drugs introduced in 2017 costs at least $ 500 , while the average price of a new drug brought to market was $ 150,000 , compared with $ 79,000 five years ago . By 2020 , US costs are forecast to double yet again , while the global market for cancer therapeutic medicines is expected to reach $ 200bn .